Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Containing Antimicrobial Resistance - WHO Policy Perspectives on Medicines, No. 010, April 2005
(2005; 6 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentThe problem of antimicrobial resistance
View the documentMeasuring the problem through surveillance
View the documentEpidemiological surveillance of antimicrobial resistance
View the documentSurveillance of antimicrobial use
View the documentCore national strategies to contain AMR
View the documentConclusion
View the documentKey Documents
 

Key Documents

World Health Organization. How to Investigate Drug Use in Health Facilities: Selected Drug Use Indicators. Geneva: WHO; 1993 (WHO/DAP/93.1).

World Health Organization. WHO Global Principles for the Containment of Antimicrobial Resistance in Animals Intended for Food: Report of a WHO Consultation. Geneva: WHO; 2000 (WHO/CDS/CSR/APH/2000.4).

World Health Organization. WHO Global Strategy for Containment of Antimicrobial Resistance. Geneva: WHO; 2001 (WHO/CSR/DRS/2001.2).

World Health Organization. Surveillance Standards for Antimicrobial Resistance. Geneva: WHO; 2001 (WHO/CSR/DRS/2001.5).

World Health Organization. Infection Control Programmes to Control Antimicrobial Resistance. Geneva: WHO; 2001 (WHO/CSR/DRS/2001.5).

World Health Organization. Promoting Rational Use of Medicines: Core Components. WHO Policy Perspectives on Medicines No.5, Geneva: WHO; 2002 (WHO/EDM/2002.3).

World Health Organization. Monitoring Antimicrobial Usage in Food Animals for the Protection of Human Health: Report of a WHO Consultation. Geneva: WHO; 2002 (WHO/CDS/CSR/EPH/2002.11).

World Health Organization. Implementing Antimicrobial Drug Resistance Surveillance and Containment for HIV, Tuberculosis and Malaria: An Outline for National Programmes. Geneva: WHO; 2003 (WHO/CDS/RMD/2003.2).

World Health Organization. Drug and Therapeutics Committees: A Practical Guide. Geneva: WHO; 2004 (WHO/EDM/PAR/ 2004.1).

All documents available on http://www.who.int/medicines

Contacts in WHO Regional Offices:

Regional Office for Africa:
Dr Jean-Marie Trapsida
Coordinator, Essential Drugs and Medicines Policy
Tel: +242 8 39258 E-mail: trapsidaj@afro.who.int

Regional Office for the Americas:
Dr Jorge A.Z. Bermudez
Essential Medicines, Vaccines and Health Technologies
Tel: +1 202 974 3104 E-mail: bermudej@paho.org

Regional Office for the Eastern Mediterranean:
Dr Zafar Mirza
Regional Adviser, Essential Medicines and Biologicals
Tel: +00 202 276 55 61 E-mail: mirzaz@emro.who.int

Regional Office for Europe:
Mr Kees de Joncheere
Pharmaceuticals
Tel: +45 3 917 14 32 E-mail: cjo@who.dk

Regional Office for South-East Asia:
Dr Krisantha Weerasuriya
Regional Adviser, Essential Drugs and Medicines Policy
Tel: +91 11 2337 0804 (ext 26314)
E-mail: weerasuriyak@whosea.org

Regional Office for the Western Pacific:
Dr Budiono Santoso
Regional Adviser
Tel: +63 2 528 9846 E-mail: santosob@wpro.who.int

Contacts at WHO Headquarters:

Medicines Policy and Standards
Health Technology and Pharmaceuticals Cluster
WHO Headquarters, Geneva, Switzerland:

Dr Hans V. Hogerzeil
Director, Medicines Policy and Standards
Tel: +41 22 791 3528 E-mail: hogerzeilh@who.int

Dr Clive Ondari
Team Coordinator, Policy, Access and Rational Use
Tel: +41 22 791 3676 E-mail: ondaric@who.int

Dr Lembit Rägo
Team Coordinator, Quality and Safety: Medicines
Tel: +41 22 791 4420 E-mail: ragol@who.int

© World Health Organization 2005.

All rights reserved. Publications of the World Health Organization can be obtained from Marketing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int).

The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

The World Health Organization does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use.

to previous section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014